Project Details
Description
A liquid biopsy-derived proteogenomic biomarker for 177Lu-PSMA-617 radioligand therapy in patients with prostate cancer
| Status | Active |
|---|---|
| Effective start/end date | 1/1/24 → 12/31/26 |
Funding
- AMERICAN CANCER SOCIETY, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.